Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
54.77
-2.41 (-4.21%)
At close: Apr 28, 2026, 4:00 PM EDT
55.68
+0.91 (1.66%)
After-hours: Apr 28, 2026, 7:29 PM EDT

Spruce Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Market Capitalization
148931711926105
Upgrade
Market Cap Growth
1114.30%437.50%-85.46%361.35%-75.29%-81.46%
Upgrade
Enterprise Value
10084-3916-5819
Upgrade
Last Close Price
54.7787.1131.50219.7582.31334.50
Upgrade
PS Ratio
--3.5311.82--
Upgrade
PB Ratio
1.772.190.601.560.380.94
Upgrade
P/TBV Ratio
3.482.190.601.560.380.94
Upgrade
EV/Sales Ratio
---1.62--
Upgrade
Debt / Equity Ratio
0.020.020.100.060.090.06
Upgrade
Net Debt / Equity Ratio
-1.13-1.13-1.25-1.20-1.06-0.74
Upgrade
Net Debt / EBITDA Ratio
1.691.690.641.771.541.96
Upgrade
Net Debt / FCF Ratio
1.451.450.642.761.752.29
Upgrade
Asset Turnover
--0.070.11--
Upgrade
Quick Ratio
5.115.112.543.946.3510.03
Upgrade
Current Ratio
5.175.172.904.186.7210.36
Upgrade
Return on Equity (ROE)
-109.24%-109.24%-100.70%-66.10%-51.35%-32.43%
Upgrade
Return on Assets (ROA)
-36.41%-36.41%-47.06%-34.28%-27.86%-18.17%
Upgrade
Return on Capital Employed (ROCE)
-66.60%-66.60%-187.40%-65.40%-64.60%-35.80%
Upgrade
Earnings Yield
-26.33%-41.79%-305.73%-40.17%-178.61%-40.41%
Upgrade
FCF Yield
-22.52%-35.74%-322.61%-27.90%-161.25%-34.37%
Upgrade
Buyback Yield / Dilution
-39.34%-39.34%-7.14%-63.68%-0.71%-289.93%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.